Detalles de la búsqueda
1.
Association between baseline hemodynamic indices, cardiotoxicity risk, and survival in women with breast cancer.
J Nucl Cardiol
; 35: 101849, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38508443
2.
Acute skin toxicity of conventional fractionated versus hypofractionated radiotherapy in breast cancer patients receiving regional node irradiation: the real-life prospective multicenter HYPOBREAST cohort.
BMC Cancer
; 22(1): 1318, 2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526987
3.
Treatment algorithm and prognostic factors for patients with stage I-III carcinoma of the anal canal: a 20-year multicenter study.
Mod Pathol
; 34(1): 116-130, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32728225
4.
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial.
Lancet Oncol
; 20(12): 1740-1749, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31629656
5.
HPV insertional pattern as a personalized tumor marker for the optimized tumor diagnosis and follow-up of patients with HPV-associated carcinomas: a case report.
BMC Cancer
; 19(1): 277, 2019 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30922253
6.
Psychological and social determinants of physical activity from diagnosis to remission among French cancer patients (PERTINENCE): protocol for a mixed-method study.
BMC Public Health
; 19(1): 1053, 2019 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387577
7.
Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE).
BMC Cancer
; 18(1): 719, 2018 Jul 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29976172
8.
Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.
Neurosurg Rev
; 41(3): 787-797, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29105011
9.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28841909
10.
Brachytherapy for favorable prognostic prostate cancer in men up to 60 years of age: Long term follow-up.
Brachytherapy
; 23(3): 301-308, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38480107
11.
Adjuvant pulse-dose-rate brachytherapy for oral cavity and oropharynx carcinoma: Outcome and toxicity assessment of 66 patients.
J Contemp Brachytherapy
; 16(1): 21-27, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38584888
12.
Evaluating the feasibility and acceptability of an adapted fencing intervention in breast cancer surgery post-operative care: the RIPOSTE pilot randomized trial.
Front Oncol
; 14: 1335442, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38665959
13.
Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer.
Clin Transl Radiat Oncol
; 44: 100702, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38111609
14.
Dosimetric predictive factors for facial nerve paralysis after cyberknife® stereotactic radiotherapy for vestibular schwannomas: A single institution experience of 88 patients.
Radiother Oncol
; 181: 109519, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736859
15.
CyberKnife® stereotactic radiation therapy for stage I lung cancer and pulmonary oligometastases: is fiducial implantation still relevant?-a cohort study.
J Thorac Dis
; 15(9): 4636-4647, 2023 Sep 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37868838
16.
A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial.
Eur Urol Open Sci
; 54: 80-87, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37545850
17.
Prognostic factors of local control and progression-free survival in AJCC stages T1 and T2 cervical cancer patients treated with adjuvant brachytherapy after chemoradiotherapy.
J Contemp Brachytherapy
; 15(1): 27-36, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36970434
18.
Outcomes following brachytherapy boost for intermediate- and high-risk prostate cancer: A retrospective bicenter study by the SFRO brachytherapy group.
Radiother Oncol
; 180: 109460, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638842
19.
The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study.
Eur Urol Oncol
; 6(4): 399-405, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754722
20.
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Radiother Oncol
; 183: 109542, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813175